SW-1463 Cells
CAD$759.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The SW-1463 cell line is derived from a human adenocarcinoma of the rectum. It is part of the extensive SW series of cancer cell lines, which have been characterized for their unique genetic and molecular profiles. SW-1463 is notable for its epithelial morphology and tumorigenic potential in immunocompromised mice. The cell line displays a stable growth pattern under standard culture conditions and has been extensively used in cancer biology and drug development studies. Genomic profiling of SW-1463 has revealed several mutations associated with oncogenesis, including alterations in the KRAS pathway. This makes the cell line a valuable tool for studying colorectal cancer and testing therapies targeting RAS/RAF/MEK/ERK signaling. Additionally, transcriptomic analyses have highlighted dysregulated expression of genes involved in cell cycle regulation and apoptosis, further emphasizing its utility in cancer research. SW-1463 has also been integrated into high-throughput drug screening programs, where it has shown diverse responses to chemotherapeutic agents and targeted therapies. These studies provide insights into the mechanisms of drug resistance and sensitivity, aiding in the development of personalized medicine strategies. |
|---|---|
| Organism | Human |
| Tissue | Rectum |
| Disease | Rectal adenocarcinoma |
| Applications | 3D culture, Cancer research |
| Synonyms | SW1463, SW 1463 |
Characteristics
| Age | 66 years |
|---|---|
| Gender | Female |
| Ethnicity | European |
| Morphology | Epithelial |
| Growth properties | Adherent |
Regulatory Data
| Citation | SW-1463 (Cytion catalog number 300623) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_1718 |
Biomolecular Data
| Surface antigens | Blood type A, Rh + |
|---|---|
| Protein expression | Keratin |
| Antigen expression | Carcinoembryonic antigen (CEA) |
| Isoenzymes | ES-D, 1, G6PD, B, PEP-D, 1, PGD, A, PGM1, 1, PGM3, 1-2 |
| Tumorigenic | Yes, in nude mice |
| Ploidy status | Hypertriploid |
| Karyotype | 2n=46 |
Handling
| Culture Medium | DMEM:Ham's F12 (1:1), w: 3.1 g/L Glucose, w: 2.5 mM L-Glutamine, w: 15 mM HEPES, w: 0.5 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | TrypLE Express (Life Technologies) |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 300623-260423 | Certificate of Analysis | 05. Dec. 2025 | 300623 |
| 300623-021025 | Certificate of Analysis | 05. Dec. 2025 | 300623 |
-
Related products
Related products
SW480 CellsOrganism Human Tissue Colon Disease Adenocarcinoma, Grade IV, Dukes' type B. CAD$545.10*